Contrast Media Market Outlook, Size, Share & Key Companies by 2030

Market Summery

Market Research Future (MRFR) predicts the Global Contrast Media Market Share is projected to grow USD 4.2 billion at a CAGR 4.01% during the forecast period of 2023 – 2030. Contrast Media is a substance that enhances the visibility of internal organs during radiography.  Medical imaging plays a crucial role in diagnosis of diseases, like GI disorders, cancer diagnosis, and cardiovascular complications.

The World Health Organization (WHO) reported that by 2020, three-quarters of global deaths will be caused due to chronic diseases of which 71-75% of deaths will be due to cardiac related problems. Early detection of such ailments can help provide patients with better treatment.  The increase in prevalence of chronic disease and cancer patients necessitates better diagnostic techniques provoking elevated use of contrast media. This is expected to bolster the contrast media market in the forecast period.

Medical imaging techniques like, computed tomography (CT) and magnetic resonance imaging (MRI), extensively use contrast media for deriving images of internal organs of a body.  The increase in the number of both public and private diagnostic centres availing such sophisticated medical imaging techniques is another factor identified to propel the market expansion. Owing to technical advancements, the burgeoning healthcare industry is expected to largely influence the contrast media market.

For example, in 2017, GE Healthcare received its FDA approval for Visipaque™ (iodixanol) Injection, a imaging agent that can be used in coronary CT angiography.  Ascelia Pharma, in 2018 announced that it will develop manganese-based contrast media products, which would likely be a safer alternative to gadolinium-based contrast media agents. Designing syringeless contrast media injectors to  improve the route of administration of contrast media, for better patient compliance. Such medical advancements are providing a platform for launching innovative products. MRFR forecast that launch of new products can have a positive impact on the global contrast media market growth in the near future.

Segmental Analysis

The segmental study of the Global Contrast Media Market Outlook gives a compendious market overview that highlights key points of the market that benefits our clients to identify growth opportunities of the market. The contrast media market study is segmented into type, procedure, application, and route of application.

Based on the type, the market is segmented into intravenous contrast materials, iodine-based contrast media agents, and others.

Based on the application, the market is segmented into nephrological disorders, oncology, cardiovascular disorders, and others.

Based on the route of administration, the market is segmented into injectable, rectal, and oral.

Key players

Global contrast media market players are as below

AMAG Pharmaceuticals (US)

Bracco Diagnostic Inc. (Italy)

Lantheus Medical Imaging (U.S.)

Covidien (Ireland)

Mallinckrodt Pharmaceuticals (UK)

Targeson (US)

nanoPET Pharma GmbH (Germany)

NanoScan Imaging (US)

Medrad Inc. (US)

Guerbet Group (France)

Subhra Pharma Private Limited (India)

GE Healthcare (US)

CMC Contrast AB (Sweden)

Daiichi (Japan)

Bayer Healthcare Pharmaceuticals (Germany)

Regional Insights

MRFR’s regional analysis of the Contrast Media Market insight gives a holistic approach towards the demographic progress of the market in the forecast years. Based on the region, the contrast media market is segmented into Asia Pacific, North America, Europe, and the Rest-of-the-World (RoW).

North America is expected to dominate the market, holding a significant market share owing to its strong technological infrastructure. Increase in medical tourism, rise in the number of cancer patients and patients suffering from chronic disorders, and market players likely to deliver cost-competitive contrast media products are factors which are predicted to fuel the regional market growth. 

Robust economic improvement, existence of influential market players, and technological advancements in the European region can augment the regional market proliferation.

The contrast media market in the Asia Pacific region, led by the rapidly proliferating healthcare sector and developing economy, has emerged as a promising market, globally. Increasing markets in countries, such as Japan, China, and India, are pushing up the growth in the regional market. Moreover, the APAC Contrast Media Market is driven by the rising population and the spreading awareness towards the functionalities of contrast media.

The rapidly growing healthcare industry and emerging economies like India, Japan, and China in the Asia Pacific region, a huge population, and increase in awareness towards benefits of contrast media are market dynamics expected to drive the regional market growth.

Related reports

https://healthcaresubmission.blogspot.com/2023/09/pharmaceutical-sterility-testing-market.html

https://medium.com/@suzzensten/pharmaceutical-sterility-testing-market-size-trends-growth-and-forecast-by-2032-e7be3ee4a83c

https://www.patreon.com/posts/pharmaceutical-89914746?utm_medium=clipboard_copy&utm_source=copyLink&utm_campaign=postshare_creator&utm_content=join_link

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Smart Pills Market Outlook, Size, Share & Key Companies by 2032

Market summery

Market Research Future (MRFR's) study on the global smart pills market share is projected to grow USD 2.01 billion by 2032 at a CAGR of 15.9% over the forecast period of 2023-2032. MRFR further asserts that the smart pills market is touted to reach USD 1,800 Mn by the end of 2032.

Amidst cut-throat competition, reimbursement issues, and expiry of blockbuster patent drugs, there is immense pressure on the healthcare sector to innovate diagnosis solutions. This has provided fuel for the advancement and commercialization of the smart pill technology which has been there for decades.

Smart pills are aligned with smart pills such as greater flexibility, precise delivery, real-time measurements, and monitoring of GI tract, and controlled operation or performance have acted as factors which can be employed to great advantage in drug development. They have several important applications, especially in diagnosis.

With the surge in the occurrence of chronic diseases, especially gastrointestinal diseases, smart pills are increasingly emerging as an effective method of endoscopy. Lifestyle diseases such as gastroesophageal reflux disease (GERD), obesity, and gastric ulcers are on the rise due to rapid lifestyle changes and unhealthy eating habits. This has induced high demand for on-site diagnosis, and, in turn, drive the market for smart pills. Surging prevalence of colon cancer is a key factor which is motivating the growth of the smart pills market.

Smart pills have been a breakthrough in gastrointestinal tract diagnosis and are set to replace conventional methods of diagnosis such as colonoscopy and endoscopy. Capsule endoscopy has cropped up as an effective method to perform endoscopy which is non-invasive and causes very little discomfort. Increasing consumer preference for minimally invasive medical procedures is likely to induce greater demand within the smart pills market.

Application of smart pills in monitoring pH, temperature, pressure, and drug adherence are further expected to catapult the growth of the market. Considerable research in the field of smart pills purveyed by heavy investments is also favoring the growth of the market. Other factors fostering market growth include conducive reimbursement landscape and increasing geriatric population. On the other hand, the market growth is restricted by factors such as regulatory restrictions and high costs of smart pills.

Segmentation

The global smart pills market has been segmented based on application, target area, disease indication, and end user.

By application, the smart pills market has been segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The capsule endoscopy segment has been further segmented into small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. The patient monitoring segment has been further segmented into capsule pH monitoring and others.

By target area, the smart pills market has been segmented into esophagus, small intestine, large intestine, and stomach.

By disease indication, the smart pills market has been segmented into esophageal diseases, small bowel disases, colon diseases, and others.

By end user, the smart pills market has been segmented into hospitals, diagnostic center, and research institute.

Competitive Landscape

Global smart pills market players are CapsoVision, Inc., Proteus Digital Health, Inc., JINSHAN Science & Technology, MEDTRONIC, Check-Cap, BDD Limited, Olympus Corporation, PENTAX Medical, FUJIFILM Holdings Corporation, MEDISAFE, INTROMEDIC, and RF Co., Ltd. are the notable players in the global smart pills market.

Regional Analysis

By region, the smart pills market outlook has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

Conducive reimbursement scenario, the surging prevalence of chronic diseases, a nd fast uptake of advanced technology are the factors supporting the growth of the market in the region. The Americas account for the foremost share of the smart pills market.

Europe follows the Americas closely and accounts for the second most significant share of the smart pills market. Robust healthcare infrastructure, the high incidence rate of lifestyle-related diseases such as obesity, gastroesophageal reflux disease (GERD), and gastric ulcers have generated high demand for smart pills in the region. Moreover, European countries invest heavily in healthcare which acts as a plus for the growth of the market.

The APAC market is poised to perform relatively well and emerge as the fastest-growing market for smart pills. Percolation of advanced healthcare technologies in the region coupled with high healthcare expenditure in the developing countries of the region favors the growth of the market. Besides, increase in geriatric population and prevalence of various chronic diseases contribute to the growth of the market.

The minimum share of the smart pills market is held by MEA. Lack of knowledge, low healthcare penetration, and poor economic conditions, especially in the African region is hindering the growth of the market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

North America Dental Consumables Market Size is forecasted to grow by 2032

Dental Consumables Market – Overview

The focus towards dental health has increased the demand for dental consumables significantly over the forecast period. Market focused reports related to the healthcare domain among others recently have been made available by Market Research Future which publishes reports on this market. The North America Dental Consumables Market Size is expected to grow at a CAGR of 2.7% in the forecast period 2023-2032

Increased number of dental practitioners who are utilizing dental consumables has risen considerably in the past few years. Advances in dental procedures have positively reinforced the growth trends of the dental consumables market. Increasing numbers of dental professionals around the world are expected to be instrumental in the development of the market in the coming years. Innovations related to the various areas of dentistry are significant in the expansion of the market. Dental consumables are extensively used due to an escalation in demand for minimally invasive cosmetic dental procedures, particularly in aesthetic dentistry.

Detailed Regional Analysis

The regional analysis of the industry for dental consumables globally comprises of regions such as the Middle East and Africa, Europe, North America, Latin America and the Asia Pacific. The Americas region controls the main market portion and will carry on its role in guiding the market for the duration of the given forecast period due to the high acceptance of novel technologies and increased healthcare expenditures within the region. With the demand for dental consumables growing, due to the developments in dental treatments, shifting demographic trends, and a combination of other factors, the market is expanding at a good pace. Since some of the nations with better medical and healthcare facilities such as Brazil, US, and Canada. The European region is the second significant market due to the presence of well-developed economies and a sound healthcare structure. The rising skills of the oral healthcare domain across altered nations such as the Greece, U.K., Spain, and Italy among others have upgraded the possibility for development of the European region for dental consumables.

Intensification of focus on vendors from emerging markets, such as the Asia Pacific region is expected to improve the pace of market expansion. Additionally, growing demand for refining aesthetic appearance and developing awareness about dental consumables is estimated to positively add to the market development. In addition, the rise in the dental tourism for this region is expected to fuel the market expansion during the forecast period.

Competitive Analysis

The accelerating levels of diversification in the industry, have permitted the companies to use many opportunities available in the industry. The companies in this market are acclimatizing to the state of events by employing portfolio upgrades and preserving financial liquidity. The market value has been enhanced by the constant delivery of customer value. The market competitors are creating their blueprints for corporate strategy in a way that can bring about the best results for development in the current scenario, while also alongside enhancing their product’s value. The prospect for development in the industry appears to be promising through the forecast period. The capability to fuel competitive capabilities is one of the chief causes powering their efforts in this period. Moreover, the contenders are handling the competitive environment by driving the market growth factors to their advantage.

North America Dental Consumables Market Players are

Institut Straumann AG

Henry Schein Inc

Patterson Dental Supply Inc.

Dentsply Sirona

Kerr Corporation

Danaher Corporation

GC orthodontics

Planmeca Oy

American Orthodontics

Industry Segments

The north america dental consumables market insight is segmented on the basis of type and region. The type segment of the market comprises of dental prosthetics, dental restorative material, dental implants and dental regenerative material among others. The region-based segmentation of the dental consumable industry consists of geographical areas such as Europe, Latin America, North America, Middle East, Asia Pacific and Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Immunofluorescence Assay Market Players, Segmentation & Analysis by Recent Trends

The global immunofluorescence assay market size is growing pervasively. The market growth attributes to the increase in biological studies in R&D for the detection of biomolecules like glycans, proteins, and small biological and non-biological molecules of various diseases. Also, immunofluorescence assays are primarily used for rapid and sensitive diagnostics of various chronic diseases such as cancer, autoimmune diseases, infectious diseases like HIV, neurological disorders such as Alzheimer's and Parkinson's diseases.

With the intervention of the COVID-19, the immunofluorescence assay industry overview is witnessing a massive demand across the globe. This is due to the rising usages of immunofluorescence assays in the development of antibodies that can detect sars-Cov-2 in patient samples. According to Market Research Future (MRFR), the global Immunofluorescence Assay Market is expected to reach USD 2.7 Billion by 2030 at 6.10% CAGR during the forecast period 2022-2030.

Advancements in medical technology, alongside the increasing R&D funding by industry leaders and governments, boost the market growth. Additionally, rising numbers of preclinical research, alongside the rising studies on antibody therapies, advanced drug discoveries, and oncology diseases, accelerate the market growth. Growing collaborations between research institutes and biotechnology companies are expected to drive the growth of the immunofluorescence assay market.

Conversely, the high cost of immunofluorescence assay products such as diagnostic kits is expected to restrict the market growth during the forecast period. Also, factors such as risks of cross contaminations and shortage of skilled labor & weak detection signals are estimated to impede the growth of this market.  Nevertheless, growing advancements in biotechnology & medical science would support the growth of the market, bringing about cost-effective immunofluorescence assay. 

Global Immunofluorescence Assay Market – Competitive Analysis

Highly competitive, the global immunofluorescence assay market appears fragmented due to the presence of several well-established players. To gain a larger competitive advantage, players incorporate strategies such as mergers & acquisitions, collaborations, expansion, and product/technology launch. Top players make huge investments for R&D and clinical trials to develop these assays. Pharmaceutical companies are the largest investors in the immunofluorescence assay market. 

Major Players: 

The global immunofluorescence assay market Players leading include Abcam plc., Thermo Fisher Scientific, BioLegend, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., BioTek Instruments, Inc., Bio-Rad Laboratories, Inc., Zyagen Cell Signaling Technology, Inc., PerkinElmer Inc., Becton Dickinson and Company, Merck, Agilent Technologies, TCS Biosciences Ltd, and Maxvision Biosciences Inc., among others. 

Global Immunofluorescence Assay Market – Segmentation

The report is segmented into five dynamics; 

By Technique: Primary (Direct) Immunofluorescence Assays and Secondary (Indirect) Immunofluorescence Assays (Salt split technique, Antigenic mapping method, Double Staining method), Micro Immunofluorescence.

By Product Type: Antibodies, Kits & Reagents, Instruments, Microscopes, Imaging Analysis Systems, Labeling dyes, Species Product Type, and others.

By Application: Clinical Research, Clinical Diagnostics, Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Neurological Diseases, Research & Development, and others.

By End-User: Biotechnology Companies, Hospitals & Research Institutes, Contract Research Organizations, Diagnostic centers, and others.

By Regions:  Americas, Europe, Asia Pacific, and Rest-of-the-World.

Global Immunofluorescence Assay Market – Regional Analysis

North America dominates the global immunofluorescence assay market insights. The largest market share attributes to the high prevalence of chronic diseases and rising R&D investments within this region. Also, the rising adoption of advanced systems for early diagnosis of diseases drives the regional market growth. Moreover, the advancement in the development techniques and increasing use of nanotechnology in the development of immunofluorescence assay fostered the growth of the regional market.

The US, among other North American countries, holds the largest share in the regional market. Besides, the presence of vast numbers of biotechnology & pharmaceutical companies impacts the regional market growth positively. The North American immunofluorescence assay market is estimated to retain its leading position throughout the assessment period.

Europe stands second in the immunofluorescence assay market. The market is driven by the increasing prevalence of myriads of chronic diseases such as cancer and the rapidly growing biotechnology sector in Europe. Moreover, substantial R&D investments by the public and private sectors, alongside the increasing R & D in biotechnology, foster the market growth in the region. The European immunofluorescence assay market is projected to create a substantial revenue pocket over the review period.

The immunofluorescence assay market in the Asia Pacific region is growing rapidly. Factors such as the growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure, and increasing R&D activities in the biotechnology sector influence the market in this region. Also, the presence of major market players in China, India, and Japan drive market growth. Rising government initiatives increase the size of the immunofluorescence assay market in the region.

The region witnesses rising developments of immunofluorescence assay products, while several products are under the pipeline, which is carried out under license agreements. The APAC immunofluorescence assay market is expected to grow at an impressive CAGR during the predicted period.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Dysmenorrhea Treatment Market Size : A Global Analysis of the Market Trends

Market Overview

The global Dysmenorrhea Treatment Market Size is expected to cross USD 7.69 billion by 2032 at a CAGR of 8.20% during the forecast period 2023-2032.

Recently the outbreak of the Covid-19 pandemic has globally vastly impacted women's health. The pandemic affected the female population and made them face an extended period of illness that also inclined towards the increasing duration of the menstrual cycle, which severely affected the women and led to several health issues.

Dysmenorrhea is generally classified as menstrual cramps, which harshly affects women's health. The major factors attributed to channelizing the Dysmenorrhea Treatment Market. growth are the rapidly increasing rate of Dysmenorrhea among teenage girls. Due to genetic disorders, menstrual cramps are also gripping rapid effects among women. Concerns beholding to the harsh effects and increasing availability of various products are implied to curb the market's growth. The increasing population of females and rapidly growing menstrual health issues is developing openings for Dysmenorrhea Treatment Market.

Key Players:

Global dysmenorrhea treatment market Players are including.  

Johnson & Johnson (US),

GlaxoSmithKline PLC (UK),

F. Hoffmann-La Roche Ltd (Switzerland),

Bayer AG (Germany),

Focus Consumer Healthcare, LLC (US),

Novartis AG (Switzerland),

Pfizer, Inc. (US),

Reckitt Benckiser Group plc. (UK),

Sanofi S.A. (France) and

Viatris Inc. (US) among others.

Market Segmentation: 

The Dysmenorrhea Treatment Market has been segmented based on type, type of treatment, and end-user.

By type includes primary Dysmenorrhea, which happens before menstrual bleeding women will face recurring and very painful menstrual cramps. The pain is likely to be high in the back, lower abdomen, or thigh and mild to severe. It lasts up to 12 to 72 hours. Nauseous, fatigue, diarrhea, and vomiting are some of the symptoms of primary Dysmenorrhea. Then comes the secondary Dysmenorrhea, and It is studied that endometriosis is the leading cause of secondary Dysmenorrhea among adolescent women.

On the factors of treatment Dysmenorrhea Treatment Market has been segmented into pain relievers, hormonal therapy, surgery, and others. The market is dealing well with the medication procedure as the growth of menstrual problems is a rising rapidly day by day. The Dysmenorrhea Treatment Market is divided into parts based on end-users, such as hospitals, clinics, research centers, and others.

Other end-users, such as ambulatory surgical centers and specialty centers, are also other end-users. In ambulatory surgical centers, methods can be performed on the same day.

Regional Analysis:

Based on the region, the global Dysmenorrhea Treatment Market has been fractionated into the Americas, Europe, Asia-Pacific, and the the Middle East and Africa. 

It is subjected that Americas accounted for the biggest share in the field of Dysmenorrhea Treatment Market. Due to the increasing number of women suffering from Dysmenorrhea, the treatment market is strongly holding its pace rapidly. Along with this, other regions are also developing their need for Dysmenorrhea Treatment Market.

Industry News:

Recently, a company known as GlaxoSmithKlinePlC, based in the UK, has involved itself with Dysmenorrhea Treatment Market and planning to introduce new medications and developmental aspects for this serious menstrual issue.

Related Reports-

Hemiplegic Migraine Market Research Report - Forecast till 2023

Medical Bionic Implant/Artificial Organs Market Research Report – Forecast to 2030

Digital 3D Printing Market Research Report - Global Forecast till 2030

 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Herbal Medicinal Products Market Size, Insights, Application & Growth Drivers

Market Insights

Herbal medicinal products are medicinal products which have been prepared using plant or other natural sources. Herbal plants have a number of medically relevant natural ingredients which can be used in the production of dietary supplements, ointments and a variety  of other medical products. Market Research Future has performed a detailed study regarding the growth of the herbal medicinal products market size is anticipated to grow USD 21.01 billion by 2032 at a healthily CAGR of 12.2 % over the assessment period from 2023 to 2032.

Due to urbanization and the adoption of busy lifestyles, chronic diseases and other lifestyle problems are at an all-time high. Consumers are increasingly becoming health conscious and aware regarding various vital ingredients in medicine and food products. As a result, increasing consumer demand has been witnessed for green label products that are largely composed of natural ingredients. Moreover, allopathic medicine famously uses synthetic chemicals and other ingredients which can cause side effects. The growing awareness regarding these ill effects of allopathic medicine is expected to drive the growth of the herbal medicinal products market. Although it is recommended that consumers consult their doctor before consumption of any medically relevant products, herbal medical products are often very safe to take and do not require a prescription. In certain parts of the world, traditional herbal medicine is still embraced, driving consistent demand. Additionally, there is a low processing cost associated with herbal medicinal products which are also expected to boost market growth over the assessment period.

Notably, the market's growth is hindered by the lack of government support for the promotion of herbal medicinal products. The presence of market players who promote herbal medicinal products which are untested and have no medicinal value is also expected to challenge market growth. However, R&D activities regarding herbal ingredients will likely mitigate some challenges and prove the market with room to grow.

Market Segmentation

The global herbal medicinal products market has been segmented on the basis of type, function, form, and region. Types of herbal medicinal products have been segmented into homeopathic medicines, traditional Chinese medicines, aromatherapy medicines, ayurvedic medicines, and others. Ayurvedic medicines possess the largest share of the market, and the segment is followed by Chinese medicine. Ayurvedic formulations are in high demand are often easily approved for distribution by the relevant regulatory authorities. 

Function has been segmented to include  cardiovascular health, general wellness, gut & digestive health, cognitive health, and others. Gut and digestive health is the dominating segment among the mentioned segments. The increasing demand and use of herbal medicinal products for digestive problems are expected to drive the market. Herbal medicines for cardiovascular health have been witnessed to have a growing demand.

Forms of herbal medicinal products have been segmented into syrups, powder, ointments, capsules, tablets, oils, and others. Tablets lead the market and are followed by capsules as they deliver the ideal dosage of herbal medicinal ingredients . Tablets and capsules are also easy to store and carry.

Key Players

Young Living Essential Oils LC (U.S.), ARKOPHARMA Laboratories Company Ltd. (France), Nature's Answer, Inc. (U.S.), TSUMURA & CO. (Japan), Ricola AG (Switzerland), Bio-Botanica Inc. (U.S.), and Sanofi-Aventis Healthcare Pty Ltd. (Australia) are the more prominent market participants in the global herbal medicinal products market. MRFR has identified and recorded pertinent information regarding these players competitive roles in the market.

Regional Analysis

MRFR has covered regions such as Asia Pacific, Europe, North America and Rest of the World. Europe leads the market with the largest share and is followed by the Asia Pacific regional market. Europe has been observed to be having the highest consumption and demand for herbal medicinal products. The rising awareness regarding herbal ingredients and the support of relevant government bodies for new product launches will likely be key in the region's growth. Meanwhile, the APAC is growing rapidly due to the high adoption of products which include herbal ingredients. Country-level markets such as India and China are the birthplaces of ayurvedic medicine and Chinese medicine respectively. As such the region has an affinity toward the adoption of herbal medicinal products over allopathic medicinal products.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Veterinary POC Diagnostic Market Size, Trends, Growth, and Forecast by 2030

Veterinary POC Diagnostic Market-Overview

Medical progress has led to advancements in the veterinary healthcare system, such as Point-of-Care (PoC), which permits speedy results in non-laboratory situations. According to an MRFR report, the market will earn USD 1.285 Billion by 2030 and will gain a CAGR of 9.70% during the forecast year 2022- 2030.

Accelerating pandemic illnesses such as swine flu and rabies will further promote the market. Less time spent on testing and outcomes, more precise results, a shift in diagnostic trends, and the adoption of cutting-edge technologies is likely to fuel the veterinary Point-of-Care (PoC) diagnostic market size.

Competitive Analysis

The reliance on online commerce for sales is expected to increase significantly during the forecast period, prompting market stakeholders to invest more in its growth. Due to the return of COVID cases in many locations, the market may exhibit constrained growth. The continuation of occasional lockdowns in numerous regions may cause the market expansion to be hampered if resources such as labor and supply chains are severely impacted. The global market is expected to diversify in operational techniques as innovative models for operation and delivery are implemented. It is projected that the emphasis on accumulating reserves of resources to deal with unexpected crises would impact future market trends. Government assistance is expected to support worldwide market development in the next years. Market developments and research are expected to generate attractive growth opportunities in the next years.

The prominent companies in the veterinary POC diagnostic market player are Idexx Laboratories, Inc. (US), Woodley Equipment Company Ltd. (UK), Zoetis, Inc. (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Minxray, Inc. (US), AniPoC, Ltd. (UK), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Carestream Health, Inc. (US), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), Heska Corporation (US), Randox Laboratories, Ltd. (UK), GE Healthcare (US), QR s.r.l. (Italy), Sedecal (Spain), and Examion GmbH (Germany).

Segmental Analysis

The segmental study of the veterinary POC diagnostic market overview has been conducted based on the technology, application, product, animal type, and end user. The market based on end users has been segmented into hospitals & clinics and home care. The market has been segmented into companion animals and livestock animals based on the animal type. The veterinary POC diagnostic market has been segmented into consumables and instruments based on the type. The market has been segmented into immunodiagnostics, urinalysis, clinical biochemistry, hematology, and molecular diagnostics based on technology. The market has been segmented into orthopedics & traumatology, virology, clinical pathologyoncology, parasitology, gynecology, cardiology, bacteriology, and neurology based on the application.

Detailed Regional Analysis 

In the forecast period, the North American market generated outstanding revenue. The growing adoption of pet animals for companionship, coupled with the high animal healthcare expenditure, will boost the North American veterinary POC diagnostic market. Advances in veterinary diagnostics and multiple laboratories in the region applying innovative molecular diagnostic techniques will propel market expansion even further. The European market will grow at a 7.8 percent annual rate during the predicted period. The collective need for animal products and an increasing emphasis on biologicals, which aids in the development of various vaccines, are driving the rise of the animal diagnostics business in Europe. Elevated animal food consumption puts strain on animal farms, increasing demand for animal diagnostics to reduce the spread of zoonotic and animal foodborne diseases. The Asia-Pacific region is expected to grow at the quickest rate throughout the forecast period, owing to the rapid development of manufacturing facilities in developing economies such as China and India.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013